Development · 28 Aug 2026
1 publisher has reported this development. Each act of reporting is below, cited.
The Trump administration plans to announce new drug-pricing agreements with midsized biotech companies where participating companies will provide discounts on outpatient drugs to state Medicaid programs in exchange for exemption from Medicare discount pilot programs and tariff relief.
The Trump administration plans to announce a new round of drug-pricing agreements with several midsized biotech companies where companies will provide discounts on outpatient drugs to state Medicaid programs and be exempt from Medicare discount pilot programs in exchange.
This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.